321 related articles for article (PubMed ID: 19244169)
1. In vivo imaging, tracking, and targeting of cancer stem cells.
Vlashi E; Kim K; Lagadec C; Donna LD; McDonald JT; Eghbali M; Sayre JW; Stefani E; McBride W; Pajonk F
J Natl Cancer Inst; 2009 Mar; 101(5):350-9. PubMed ID: 19244169
[TBL] [Abstract][Full Text] [Related]
2. Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity.
Tamari K; Hayashi K; Ishii H; Kano Y; Konno M; Kawamoto K; Nishida N; Koseki J; Fukusumi T; Hasegawa S; Ogawa H; Hamabe A; Miyo M; Noguchi K; Seo Y; Doki Y; Mori M; Ogawa K
Int J Oncol; 2014 Dec; 45(6):2349-54. PubMed ID: 25269626
[TBL] [Abstract][Full Text] [Related]
3. 26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro.
Pan J; Zhang Q; Wang Y; You M
PLoS One; 2010 Oct; 5(10):e13298. PubMed ID: 20949018
[TBL] [Abstract][Full Text] [Related]
4. Visualization and characterization of cancer stem-like cells in cervical cancer.
Hayashi K; Tamari K; Ishii H; Konno M; Nishida N; Kawamoto K; Koseki J; Fukusumi T; Kano Y; Nishikawa S; Miyo M; Noguchi K; Ogawa H; Hamabe A; Seo Y; Doki Y; Mori M; Ogawa K
Int J Oncol; 2014 Dec; 45(6):2468-74. PubMed ID: 25269542
[TBL] [Abstract][Full Text] [Related]
5. Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression.
Vlashi E; Lagadec C; Chan M; Frohnen P; McDonald AJ; Pajonk F
Breast Cancer Res Treat; 2013 Sep; 141(2):197-203. PubMed ID: 24013708
[TBL] [Abstract][Full Text] [Related]
6. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment.
Lagadec C; Vlashi E; Della Donna L; Meng Y; Dekmezian C; Kim K; Pajonk F
Breast Cancer Res; 2010; 12(1):R13. PubMed ID: 20158881
[TBL] [Abstract][Full Text] [Related]
7. Imaging of radiation effects on cellular 26S proteasome function in situ.
Brush JM; Kim K; Sayre JW; McBride WH; Iwamoto KS
Int J Radiat Biol; 2009 Jun; 85(6):483-94. PubMed ID: 19401903
[TBL] [Abstract][Full Text] [Related]
8. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
[TBL] [Abstract][Full Text] [Related]
9. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
Morrison BJ; Steel JC; Morris JC
PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells.
Lagadec C; Vlashi E; Frohnen P; Alhiyari Y; Chan M; Pajonk F
Stem Cells; 2014 Jan; 32(1):135-44. PubMed ID: 24022895
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity.
Munakata K; Uemura M; Tanaka S; Kawai K; Kitahara T; Miyo M; Kano Y; Nishikawa S; Fukusumi T; Takahashi Y; Hata T; Nishimura J; Takemasa I; Mizushima T; Ikenaga M; Kato T; Murata K; Carethers JM; Yamamoto H; Doki Y; Mori M
Clin Cancer Res; 2016 Nov; 22(21):5277-5286. PubMed ID: 27166395
[TBL] [Abstract][Full Text] [Related]
12. Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients.
Lagadec C; Vlashi E; Bhuta S; Lai C; Mischel P; Werner M; Henke M; Pajonk F
BMC Cancer; 2014 Mar; 14():152. PubMed ID: 24593279
[TBL] [Abstract][Full Text] [Related]
13. Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents.
Adikrisna R; Tanaka S; Muramatsu S; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Yamaoka S; Arii S
Gastroenterology; 2012 Jul; 143(1):234-45.e7. PubMed ID: 22510202
[TBL] [Abstract][Full Text] [Related]
14. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
15. Radiation resistance in breast cancer: are CD44+/CD24-/proteosome low/PKH26+ cells to blame?
Nakshatri H
Breast Cancer Res; 2010; 12(2):105. PubMed ID: 20377923
[TBL] [Abstract][Full Text] [Related]
16. Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.
Lehmann C; Jobs G; Thomas M; Burtscher H; Kubbies M
Int J Oncol; 2012 Dec; 41(6):1932-42. PubMed ID: 23042145
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter.
Momose I; Tatsuda D; Ohba S; Masuda T; Ikeda D; Nomoto A
Cancer Sci; 2012 Sep; 103(9):1730-6. PubMed ID: 22676179
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation.
Kim K; Brush JM; Watson PA; Cacalano NA; Iwamoto KS; McBride WH
Mol Cancer Res; 2008 Mar; 6(3):426-34. PubMed ID: 18337449
[TBL] [Abstract][Full Text] [Related]
19. Visualizing the cancer stem-like properties of canine tumour cells with low proteasome activity.
Sung K; Hosoya K; Murase Y; Deguchi T; Kim S; Sunaga T; Okumura M
Vet Comp Oncol; 2022 Mar; 20(1):324-335. PubMed ID: 34719098
[TBL] [Abstract][Full Text] [Related]
20. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
